Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:23 p.m.

    📋 Horizon Therapeutics Public Ltd Co (HZNP) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 07:06:03

    Event Type: Financial Results

    Event Details:

    Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP) Reports Q3 2022 Financial Results Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 876411
    • Net Income: 60974
    • EPS: 1.07
    • Cash and equivalents: 1897300
      • anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks that Horizon’s actual future financial and operating results may differ from its expectations or goals; Horizon’s ability to grow net sales from existing medicines; impacts of the COVID-19 pandemic and actions taken to slow its spread, including impacts on supplies and net sales of Horizon’s medicines and potential delays in clinical trials; impacts of the on-going war between Russia and Ukraine; changes in inflation, interest rates and general economic conditions; the fact that Horizon’s full-year 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 355.20K 770.96K $-415.75K -53.93%
    Other Expense Net Interest Expense 22.58K 42.66K $-20.08K -47.07%
    Current Assets Prepaid Expenses Other Current Assets 428.81K 357.11K $71.70K +20.08%
    Property Equipment Net 302.26K 292.30K $9.96K +3.41%
    Current Liabilities Accounts Payable 18.54K 30.12K $-11.59K -38.46%
    Longterm Liabilities Other Long Term Liabilities 199.65K 173.08K $26.57K +15.35%
    Other Long Term Liabilities 3.12M 3.12M $-1.88K -0.06%
    Changes In Operating Assets And Liabilities Prepaid Expenses Other Current Assets 29.55K 71.58K $-42.03K -58.72%
    Changes In Operating Assets And Liabilities Accounts Payable 9.31K 11.98K $-2.67K -22.26%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN))
    • CIK: 0001492426
    • Ticker Symbol: HZNP
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories